Previous studies reported that the inhibition of IL-1β by human recombinant IL-1 receptor antagonist Anakinra or antimurine IL-1β IgG could protect kidney inflammation and fibrosis; however, the mechanism is mainly limited to one type of cell43,44. This evidence concerns the gene IL1B and nephritis.